NEON THERAPEUTICS, INC.
CIK 0001694187
Revenue (TTM)
—
Q1 Apr 2020
Net Income (TTM)
−$78.53M
−245.0% YoY
Q1 Apr 2020
EPS Diluted (TTM)
—
Q1 Apr 2020
Gross Margin
—
Q1 Apr 2020
Operating Margin
—
Q1 Apr 2020
Net Margin
—
Q1 Apr 2020
Free Cash Flow (TTM)
−$74.5M
Q1 Apr 2020
Cash
$15.05M
Q1 Apr 2020
Total Debt
—
Q1 Apr 2020
Shares Outstanding
28.97M sh
Q1 Apr 2020
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.